Literature DB >> 27773360

STING versus HIT technique of endoscopic treatment for vesicoureteral reflux: A systematic review and meta-analysis.

Te-Lu Yap1, Yong Chen2, Shireen A Nah2, Caroline Choo Phaik Ong2, Anette Jacobsen2, Yee Low2.   

Abstract

AIM: Our study aimed to compare the efficacy of two endoscopic techniques used for the correction of vesicoureteral reflux (VUR): subureteral transurethral injection (STING) and hydrodistension implantation technique (HIT).
METHODS: A systematic review was conducted using MEDLINE, Google scholar, and Cochrane databases from 1984 to 2015. Meta-analysis of the selected studies was performed to compare the extent of reflux resolution following both techniques.
RESULTS: Six observational studies met the inclusion criteria for content. These comprised 632 ureters treated by STING and 895 ureters treated by HIT procedure. All included studies utilized dextranomer/hyaluronic acid (Deflux) as the bulking agent. The overall resolution of VUR was significantly higher in HIT (82.5%) compared to STING (71.4%) [pooled odds ratio (OR)=0.54; 95% confidence interval (CI) 0.42-0.69; P<0.0001; I2=8%]. A subgroup analysis showed that HIT had better outcomes than STING for both lower grade (I-III) [OR=0.43; 95% CI 0.23-0.82; P=0.01; I2=0%] and high-grade VUR (IV-V) [OR=0.43; 95% CI 0.20-0.91; P=0.03; I2=0%]. However, there was no statistical difference in the requirement of additional injections between STING and HIT groups.
CONCLUSION: HIT is superior to STING technique for resolution of VUR after Deflux injection. However, more randomized trials with longer follow-up are necessary to demonstrate the benefit of HIT compared to STING procedure. LEVEL OF EVIDENCE: Retrospective comparative studies - level III. Copyright Â
© 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Dextranomer/hyaluronic acid; Endoscopic treatment; HIT; STING; Vesicoureteral reflux

Mesh:

Substances:

Year:  2016        PMID: 27773360     DOI: 10.1016/j.jpedsurg.2016.09.028

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

Review 1.  Endoscopic injection therapy.

Authors:  Sang Woon Kim; Yong Seung Lee; Sang Won Han
Journal:  Investig Clin Urol       Date:  2017-06-02

Review 2.  Brazilian consensus on vesicoureteral reflux-recommendations for clinical practice.

Authors:  José Murillo Bastos; Atila Victal Rondon; Marcos Giannetti Machado; Miguel Zerati; Rodrigo Lessa Pena Nascimento; Salvador Vilar Correa Lima; Adriano de Almeida Calado; Ubirajara Barroso
Journal:  Int Braz J Urol       Date:  2020 Jul-Aug       Impact factor: 1.541

3.  The learning curve of sting method for endoscopic injection treatment of vesicoureteral reflux.

Authors:  Ayhan Dalkiliç; Göksel Bayar; Hasan Demirkan; Kaya Horasanli
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

4.  Evaluation of the Diagnostic Value of Contrast-Enhanced Voiding Urosonography with Regard to the Further Therapy Regime and Patient Outcome-A Single-Center Experience in an Interdisciplinary Uroradiological Setting.

Authors:  Constantin A Marschner; Vincent Schwarze; Regina Stredele; Matthias F Froelich; Johannes Rübenthaler; Thomas Geyer; Dirk-André Clevert
Journal:  Medicina (Kaunas)       Date:  2021-01-09       Impact factor: 2.430

5.  Vesicoscopic Cross-Trigonal Ureteral Reimplantation for Vesicoureteral Reflux: Intermediate Results.

Authors:  Christian Kruppa; Guido Fitze; Katrin Schuchardt
Journal:  Children (Basel)       Date:  2022-02-21

Review 6.  Managing vesicoureteral reflux in children: making sense of all the data.

Authors:  Angelena Edwards; Craig A Peters
Journal:  F1000Res       Date:  2019-01-08

7.  Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up.

Authors:  Stanisław Warchoł; Grażyna Krzemień; Agnieszka Szmigielska; Przemysław Bombiński; Krzysztof Toth; Teresa Dudek-Warchoł
Journal:  Cent European J Urol       Date:  2017-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.